Mary Rinella, MD, is a board-certified transplant hepatolgist with 20 years of experience treating patients with complex liver disease. Dr. Rinella is an expert in fatty liver disease (steatotic liver disease). Fatty liver disease is the most common cause of liver disease in the United States. In some people, fatty liver can progress to cirrhosis and liver failure, but if caught early, can be preventable. As part of our metabolic and fatty liver diseases program, Dr. Rinella provides comprehensive liver disease assessment and treatment, including nutritional intervention, the use of medications, endoscopy and clinical trials to deliver the most advanced treatment options. 

While she has experience in treating all types of liver disease, in addition to fatty liver disease (steatotic liver disease), Dr. Rinella also has extensive interest and experience in the treatment of autoimmune and biliary liver diseases, such as autoimmune hepatitis, primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).

As part of her approach to care for liver disease patients, Dr. Rinella is passionate about using research to advance medicine. She has investigated a broad range of topics within steatotic liver disease, including the use of non-invasive measures to minimize the use of liver biopsy, steatotic liver disease before and after liver transplantation and the study of new therapies to treat steatotic liver disease, since there is still no FDA approved treatment. Dr. Rinella has published nearly 150 peer-review articles in prestigious journals, such as Nature Reviews Gastroenterology & Hepatology, Gastroenterology, Hepatology, Journal of the American Medical Association (JAMA), The Lancet and more.

Along with her clinical expertise and research accolades, Dr. Rinella is also dedicated to teaching residents and fellows, providing guidance and mentorship throughout their medical careers.